Key result
Metabolic syndrome in hypertensive patients was associated with a significantly higher prevalence of left ventricular hypertrophy (64% vs 36%, p=0.027) compared to hypertension alone.
Why the study?
To determine the impact of metabolic syndrome and obesity on the incidence and degree of severity of left ventricular hypertrophy in hypertensive patients.
Does the presence of metabolic syndrome increase the incidence and severity of left ventricular hypertrophy in hypertensive patients?
Population
55 consecutive hypertensive patients
Comparison
Hypertensive patients with MetS vs hypertensive patients without MetS
Design
Observational cross-sectional study
Authors
Loading...
Higher LVH prevalence in hypertensive MetS patients; hypothesis-generating observational link that leaves causal role and practice implications open.
Cross-Sectional (n=55)
No
Does the presence of metabolic syndrome increase the incidence and severity of left ventricular hypertrophy in hypertensive patients?
Absolute Event Rate: 64% vs 36%
p-value: p=0.027
Metabolic syndrome in hypertensive patients is associated with a significantly higher prevalence and severity of left ventricular hypertrophy, suggesting non-hemodynamic factors play a key role in cardiac remodeling.
Đorđijoski et al. (2023) conducted a cross-sectional in Hypertension with or without metabolic syndrome (n=55). Metabolic syndrome vs. Hypertension without metabolic syndrome was evaluated on Prevalence of left ventricular hypertrophy (LVH) (p=0.027). Metabolic syndrome in hypertensive patients was associated with a significantly higher prevalence of left ventricular hypertrophy (64% vs 36%, p=0.027) compared to hypertension alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: